VanDeMark Sold In Private Equity Deal | Chemical & Engineering News
Volume 90 Issue 51 | p. 18 | Concentrates
Issue Date: December 17, 2012

VanDeMark Sold In Private Equity Deal

Department: Business
Keywords: private equity, phosgene

Private equity firm Buckingham Capital Partners has sold VanDeMark Chemical to Uni-World Capital, another private equity investor, for an undisclosed sum. Buckingham purchased Lockport, N.Y.-based VanDeMark, a specialist in phosgene chemistry, for $40 million in 2007 from France’s SNPE. The Uni-World acquisition follows on the heels of another private equity to private equity deal in fine chemicals: Resilience Capital Partners’ sale of ChemDesign to Lubar & . . .

You Do Not Have Access to C&EN Protected Content.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society